Making every inhalation visible.
CAELIA Health is building the respiratory intelligence layer for inhalation therapy — starting with children living with asthma.
Our first product, SereneAir, is a smart pMDI spacer designed to measure whether medication was taken with the right dose, timing, flow, and technique — turning everyday inhalation moments into actionable respiratory insight.
Up to 90% of people using inhaled therapies make critical errors — and for children with asthma, many of these errors happen in the moments parents and care teams cannot see.
For parents, the hardest question comes after the dose.
The medication was prescribed. The inhaler was used. The child breathed in. But the decisive question remains unanswered: did the medication actually reach the lungs?
In pediatric asthma, the therapy moment often happens at home, at school, or during an acute symptom episode. Parents need more than reminders. They need objective feedback that the inhalation was performed correctly — and clinicians need better real-world insight than memory, self-reporting, and occasional check-ups.
Parents need certainty
Objective feedback after each inhalation can reduce uncertainty around dose delivery, timing, flow, and technique.
Children need guidance
Immediate, child-friendly feedback can turn a difficult daily routine into a guided therapy moment.
Clinicians need context
Structured inhalation data can help care teams understand what happens between visits — not only what is remembered during them.
Inhalation therapy fails in the moment nobody measures.
Inhalation therapy is one of the most common treatments in respiratory care. Yet the critical moment does not happen inside the clinic. It happens in everyday life — where dose delivery, breathing technique, and therapy response are largely invisible.
“You cannot optimize what you cannot see. CAELIA makes everyday inhalation therapy measurable.”
SereneAir sees the full inhalation event.
SereneAir is a device-agnostic smart spacer for standard pMDI inhalers. It is designed to capture the signals that matter during inhalation: dose, timing, flow, technique, and longitudinal respiratory patterns.
Compatible with all standard pMDI-Inhalers
Smart Spacer
Dose · Technique · Feedback · Tracking
Swappable Mouthpiece
Dose
Detect whether actuation happened and whether aerosol was present during the inhalation event.
Flow
Measure inhalation flow and volume to understand whether breathing supported effective delivery.
Timing
Connect dose release and breath phase to detect coordination errors.
Technique
Combine sensor signals to identify application errors and guide better use.
Response
Track respiratory patterns over time to support therapy monitoring and future warning-signal detection.
Every inhalation strengthens the respiratory intelligence layer.
SereneAir is not only a device. It is the first capture point for structured real-world inhalation data — creating a privacy-preserving learning loop across therapy technique, adherence, response, and risk signals.
Measure
Dose, timing, flow, technique, and respiratory patterns are captured during everyday use.
Structure
Each inhalation event becomes a structured data point instead of an invisible therapy moment.
Learn
Longitudinal patterns help improve coaching, therapy monitoring, and future risk models.
Guide
Patients, parents, and clinicians receive clearer feedback and more actionable insight.
Scale
As usage grows, CAELIA builds a respiratory intelligence layer for precision respiratory care.
The wedge is pediatric asthma. The platform is respiratory intelligence.
Multimodal sensing where single-signal tracking is not enough.
Most digital inhaler solutions focus on whether an inhaler was used. CAELIA is built to understand how it was used — and whether the inhalation event supported effective delivery.
Multimodal sensing
Ultrasonic flow, optical aerosol detection, acoustic monitoring, IMU orientation sensing, and real-time feedback in one smart spacer architecture.
Deep-tech foundation
Built on Fraunhofer engineering, protected IP, and a hardware architecture designed for medical-grade respiratory sensing.
AI-native development
CAELIA is built AI-native from the start — using modern software, simulation, data workflows, and intelligent prototyping to accelerate development in a highly regulated environment.
Respiratory data moat
Each validated inhalation event contributes to a growing longitudinal understanding of real-world respiratory therapy.
Regulatory thinking is built into SereneAir from the start.
CAELIA works with leading medical-device regulatory experts to shape a robust and internationally relevant pathway. Our development currently follows the European MDR framework, while we validate the appropriate FDA pathway for the United States.
Experienced guidance
Regulatory experts support our strategy, development priorities, and evidence planning.
MDR-oriented development
SereneAir is being developed with the European MDR framework in mind.
FDA pathway validation
In parallel, we are validating the appropriate regulatory pathway for the US market.
Backed by deep-tech, health, and venture-building ecosystems.
CAELIA is built in the Fraunhofer environment and supported by a growing network of partners, programs, and advisors across MedTech, digital health, venture building, and clinical respiratory care.
We are actively expanding our network of pediatric asthma pilot partners, regulatory advisors, strategic health partners, and venture investors who share our vision of making inhalation therapy measurable.
Logos shown for programs, networks or institutions supporting CAELIA Health. No clinical endorsement or product approval implied.
An interdisciplinary team for a hard problem.
CAELIA brings together venture building, ultrasonic sensing, medical hardware, healthcare operations, software architecture, and regulatory execution — the combination required to turn respiratory therapy into measurable intelligence.
Björn Götzfried
Strategy, venture building, fundraising, go-to-market, reimbursement, and investor relations.
LinkedIn
Rinaldo Persichini
Ultrasonic sensing, embedded hardware, industrialization, IP strategy, and medical-grade device engineering.
LinkedIn
Vanessa Torres Gangoo
Product strategy, healthcare systems, usability, clinical operations, and regulatory preparation.
LinkedInTo be announced
Firmware, connectivity, app architecture, data pipeline, cybersecurity, and software lifecycle.
Help us make inhalation therapy visible.
We are preparing CAELIA for the next stage: pediatric asthma pilots, regulatory pathway validation, clinical evidence generation, and a venture-scale respiratory intelligence platform.
For clinicians, pediatric pneumologists, clinics, and care teams interested in early feedback, pilot design, or clinical validation.
Discuss a pediatric asthma pilot →For experts in FDA, 510(k), MDR, SaMD, clinical claims, usability, and medical device strategy.
Validate the regulatory pathway →For pharma, device, payer, clinical research, and respiratory care partners exploring real-world inhalation data and therapy support.
Explore strategic partnership →For deep-tech, MedTech, digital health, and AI investors interested in the future infrastructure layer for precision respiratory medicine.
Request the investor brief →Talk to us at hello@caelia-health.com